ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,420.94
-2.21%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.601
0.29%
Brent Oil
83.695
-0.76%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) ニュース

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRDN
日付受信時刻ニュースソース見出しコード企業名
2021/07/2620 : 36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/07/2620 : 30GlobeNewswire Inc.Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business OfficerNASDAQ:VRDNViridian Therapeutics Inc
2021/07/1605 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2021/07/1605 : 22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
2021/07/1605 : 13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/07/1605 : 05GlobeNewswire Inc.Viridian Therapeutics Appoints Jennifer Moses, CPA to the Board of Directors and as Chair of the Audit CommitteeNASDAQ:VRDNViridian Therapeutics Inc
2021/07/1421 : 00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2021/07/0721 : 00GlobeNewswire Inc.Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare ConferenceNASDAQ:VRDNViridian Therapeutics Inc
2021/06/1707 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2021/06/1707 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2021/06/1707 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2021/06/1606 : 31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:VRDNViridian Therapeutics Inc
2021/06/1021 : 00GlobeNewswire Inc.Viridian Therapeutics to Participate in the JMP Securities Life Sciences ConferenceNASDAQ:VRDNViridian Therapeutics Inc
2021/06/0205 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRDNViridian Therapeutics Inc
2021/05/1805 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/05/1421 : 00GlobeNewswire Inc.Viridian Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:VRDNViridian Therapeutics Inc
2021/05/1105 : 05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
2021/05/0705 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/05/0705 : 05GlobeNewswire Inc.Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
2021/04/3021 : 32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRDNViridian Therapeutics Inc
2021/04/2619 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/04/2406 : 29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRDNViridian Therapeutics Inc
2021/04/1505 : 17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:VRDNViridian Therapeutics Inc
2021/03/2705 : 23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRDNViridian Therapeutics Inc
2021/03/2705 : 18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRDNViridian Therapeutics Inc
2021/03/2605 : 05GlobeNewswire Inc.Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
2021/03/2317 : 00GlobeNewswire Inc.Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of I...NASDAQ:VRDNViridian Therapeutics Inc
2021/03/1605 : 39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRDNViridian Therapeutics Inc
2021/03/1021 : 18Edgar (US Regulatory)Schedule 13gNASDAQ:VRDNViridian Therapeutics Inc
2021/03/1006 : 30GlobeNewswire Inc.Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate UpdateNASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

最近閲覧した銘柄

NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
FX
USDGBP
US Dollar vs Sterling
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
FX
USDJPY
US Dollar vs Yen
FX
USDEUR
US Dollar vs Euro
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有